If Teva knows it is not violating MNTA's patents, then it possesses information that no one else has. It is my belief that it would be happy to keep MNTA in the dark as long as possible. Why should it want a quick trial if it can launch at risk (with no risk)?
News 
Market Data 
Discover 
AI
